Format
Sort by
Items per page

Send to

Choose Destination

Best matches for citalopram AND cognitive therapy AND pharmacotherapy:

Search results

Items: 1 to 20 of 300

1.

First-episode psychosis as the initial presentation of multiple sclerosis: a case report.

Enderami A, Fouladi R, Hosseini SH.

Int Med Case Rep J. 2018 Apr 5;11:73-76. doi: 10.2147/IMCRJ.S157287. eCollection 2018.

2.

Selective noradrenaline reuptake inhibitors for schizophrenia.

Matthews PRL, Horder J, Pearce M.

Cochrane Database Syst Rev. 2018 Jan 25;1:CD010219. doi: 10.1002/14651858.CD010219.pub2. Review.

PMID:
29368813
3.

Management of Treatment-Resistant Panic Disorder.

Perna G, Caldirola D.

Curr Treat Options Psychiatry. 2017;4(4):371-386. doi: 10.1007/s40501-017-0128-7. Epub 2017 Oct 24. Review.

4.

Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice.

Wei Z, Junhong G, Xiaoyuan N, Jie W, Zhaojun W, Meina W, Wei Y, Jun Z, Jinshun Q.

Biomed Res Int. 2017;2017:1238687. doi: 10.1155/2017/1238687. Epub 2017 Sep 18.

5.

Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer's-like disease in mice.

von Linstow CU, Waider J, Grebing M, Metaxas A, Lesch KP, Finsen B.

Alzheimers Res Ther. 2017 Sep 12;9(1):74. doi: 10.1186/s13195-017-0298-y.

6.

Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia.

Viscogliosi G, Chiriac IM, Ettorre E.

J Am Med Dir Assoc. 2017 Sep 1;18(9):799-802. doi: 10.1016/j.jamda.2017.06.010. Epub 2017 Jul 21.

PMID:
28739492
7.

The Diagnosis and Treatment of Behavioral Disorders in Dementia.

Kratz T.

Dtsch Arztebl Int. 2017 Jun 30;114(26):447-454. doi: 10.3238/arztebl.2017.0447.

8.

Cross-species studies of cognition relevant to drug discovery: a translational approach.

Robbins TW.

Br J Pharmacol. 2017 Oct;174(19):3191-3199. doi: 10.1111/bph.13826. Epub 2017 May 24. Review.

PMID:
28432778
9.

Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.

Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS.

Am J Psychiatry. 2017 Jun 1;174(6):533-545. doi: 10.1176/appi.ajp.2016.16050518. Epub 2017 Mar 24. Erratum in: Am J Psychiatry. 2017 Jun 1;174(6):604.

10.

The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: A secondary analysis.

Bausch P, Fangmeier T, Zobel I, Schoepf D, Drost S, Schnell K, Walter H, Berger M, Normann C, Schramm E.

Clin Psychol Psychother. 2017 Sep;24(5):1155-1162. doi: 10.1002/cpp.2081. Epub 2017 Mar 21.

PMID:
28326653
11.

Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders.

Albayrak Y, Hashimoto K.

Adv Exp Med Biol. 2017;964:153-161. doi: 10.1007/978-3-319-50174-1_11. Review.

PMID:
28315270
12.

Differentiating residual symptoms of depression from adverse events among patients initiating treatment with an antidepressant.

Freeman MP, Fisher L, Clain A, Rabbitt R, Pooley J, Baer L, Fava M.

Ann Clin Psychiatry. 2017 Feb;29(1):28-34.

PMID:
28207913
13.

Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial.

Carney CE, Edinger JD, Kuchibhatla M, Lachowski AM, Bogouslavsky O, Krystal AD, Shapiro CM.

Sleep. 2017 Apr 1;40(4). doi: 10.1093/sleep/zsx019.

14.

Anxiety Associated with Asthma Exacerbations and Overuse of Medication: The Role of Cultural Competency.

Horikawa YT, Udaka TY, Crow JK, Takayama JI, Stein MT.

J Dev Behav Pediatr. 2017 Feb/Mar;38 Suppl 1:S56-S59. doi: 10.1097/DBP.0000000000000029.

PMID:
28141723
15.

Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI.

Crane NA, Jenkins LM, Bhaumik R, Dion C, Gowins JR, Mickey BJ, Zubieta JK, Langenecker SA.

Brain. 2017 Feb;140(2):472-486. doi: 10.1093/brain/aww326. Epub 2017 Jan 24.

16.

[Ovarian Ablation in Breast Cancer Patients and the Possibility of Influencing Treatment Side Effects].

Palácová M.

Klin Onkol. 2016 Fall;29 Suppl 3:S29-38. doi: 10.14735/amko20163S29. Czech.

PMID:
28118722
17.

Default mode network deactivation during emotion processing predicts early antidepressant response.

Spies M, Kraus C, Geissberger N, Auer B, Klöbl M, Tik M, Stürkat IL, Hahn A, Woletz M, Pfabigan DM, Kasper S, Lamm C, Windischberger C, Lanzenberger R.

Transl Psychiatry. 2017 Jan 24;7(1):e1008. doi: 10.1038/tp.2016.265.

18.

Citicoline Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Roohi-Azizi M, Arabzadeh S, Amidfar M, Salimi S, Zarindast MR, Talaei A, Akhondzadeh S.

Clin Neuropharmacol. 2017 Jan/Feb;40(1):1-5. doi: 10.1097/WNF.0000000000000185.

PMID:
28085707
19.

Effect of selective serotonin reuptake inhibitors on expression of 5-HT1AR and neurotransmitters in rats with vascular dementia.

Guo K, Yin G, Zi XH, Zhu HX, Pan Q.

Genet Mol Res. 2016 Dec 2;15(4). doi: 10.4238/gmr15049031.

PMID:
27966748
20.

The effect of remission status on work functioning in employed patients treated for major depressive disorder.

Sarfati D, Stewart K, Woo C, Parikh SV, Yatham LN, Lam RW.

Ann Clin Psychiatry. 2017 Feb;29(1):11-16.

PMID:
27901522

Supplemental Content

Loading ...
Support Center